BCAL Diagnostics Limited (ASX: BDX) is an Australian-US biotechnology company focused on transforming breast cancer screening through innovative diagnostics. For over a decade, the company has been developing diagnostic technologies designed to complement mammograms and improve screening outcomes for women worldwide. BCAL Diagnostics Limited was listed on ASX on 21 July 2021 at an issue […]
